Definium Therapeutics Inc

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$42.22

+6.04 (+16.69%)

As of Jun 24, 1:41 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 21 95%

Hold 1 5%

Sell 0 0%

Price Target

Analyst Price Target +9.0% upside

Low Target $39.37

Average Target $46.00

High Target $57.04

Current Price $42.22

Current
$42.22

Target
$46.00

$39.37 $46.00 avg $57.04

Scenario Analysis

Bear Case

$39.37

-6.8%

Low target

Base Case

$46.00

+9.0%

Avg target

Bull Case

$57.04

+35.1%

High target

Risk/Reward

5.2x

Highly favorable

Price in Context

52-Week High

$26.25

60.8% from high

52-Week Low

$6.35

+565.4% from low

Target vs 52W High

$46.00

+75.2% vs high

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	39	79%	$1,330.33	+19.1%
RDY Dr. Reddy's Laboratories	Sell	44	50%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	68%	$299.55	+24.3%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+32.1%
PFE Pfizer Inc.	Hold	36	42%	$33.90	+41.0%
BMY Bristol-Myers Squibb Co	Hold	36	39%	$174.50	+217.3%
ZTS Zoetis Inc	Buy	24	58%	$209.87	+168.5%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-33.2%